↓ Skip to main content

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

Overview of attention for article published in Antimicrobial Resistance & Infection Control, December 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
Published in
Antimicrobial Resistance & Infection Control, December 2019
DOI 10.1186/s13756-019-0652-x
Pubmed ID
Authors

Thitima Kongnakorn, Christian Eckmann, Matteo Bassetti, Eszter Tichy, Roberto Di Virgilio, Nathalie Baillon-Plot, Claudie Charbonneau

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 15%
Student > Bachelor 5 13%
Researcher 4 10%
Student > Ph. D. Student 4 10%
Other 2 5%
Other 3 8%
Unknown 16 40%
Readers by discipline Count As %
Medicine and Dentistry 8 20%
Pharmacology, Toxicology and Pharmaceutical Science 6 15%
Nursing and Health Professions 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Business, Management and Accounting 2 5%
Other 4 10%
Unknown 15 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2019.
All research outputs
#13,677,718
of 24,003,070 outputs
Outputs from Antimicrobial Resistance & Infection Control
#789
of 1,347 outputs
Outputs of similar age
#213,770
of 464,274 outputs
Outputs of similar age from Antimicrobial Resistance & Infection Control
#35
of 57 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,347 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 464,274 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.